Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Jaya Konstruksi Manggala Pratama Tbk (JKON) vs Brigit Biofarmaka Teknologi Tbk. (OBAT) Price & Performance

Jaya Konstruksi Manggala Pratama TbkTrade
Brigit Biofarmaka Teknologi Tbk.Trade

Price performance (Past 24H)

Key statistics

Jaya Konstruksi Manggala Pratama Tbk vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Jaya Konstruksi Manggala Pratama Tbk trades at Rp69 (market cap 1.09T, 1.3M 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp248 (market cap 167.37B, 96.7K 24h volume). The key difference: Jaya Konstruksi Manggala Pratama Tbk is far larger — about 6.5× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Jaya Konstruksi Manggala Pratama Tbk is more actively traded (1.3M versus 96.7K). Which is the better fit depends on your goals.

JKONOBAT
Market Cap
1.09T167.37B
Volume
1.3M96.7K
Lot
13.01K967
Turnover
88.78M23.82M
Average Price
68.24246.34
Value
88.78M23.82M
Indicative Equilibrium Price
69248
Indicative Equilibrium Volume
1.9K41

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

JKON
View details
OBAT
View details

About Jaya Konstruksi Manggala Pratama Tbk

PT Jaya Konstruksi Manggala Pratama Tbk (the company) was established dated December 23, 1982 based on Notaries Deed No.45 of Hobropoerwanto, SH. The Company’s articles of association has been amended several times, most recently by notarial deed No. 142 of Mr. Aulia Taufani, SH., dated Sep 24, 2007, concerning among others, the change Company’s capital structure and public offering.

Read more on JKON

About Brigit Biofarmaka Teknologi Tbk.

PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.

Read more on OBAT